The 3 common mainstays of angina therapy are beta-blockers, calcium channel blockers, and nitrates. These medicines treat the chest pain and provide other benefits as well. Isosorbide is a nitrate, ...

The display and use of drug information on this site is subject to express terms of use. By continuing to view the drug information, you agree to abide by such terms ...

NEW YORK, March 6 (Reuters) - CV Therapeutics Inc. said on Tuesday its angina drug Ranexa was not effective in a study of acute and long-term treatment of patients with a type of heart disease known ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...

Shijiazhuang No.4 Pharmaceutical (02005.HK) announced that it has obtained a drug production registration approval from the ...

PARIS -- Whether a person had chest pains resolved by angioplasty hinged on the nature, not the severity, of their presenting symptoms, an ORBITA-2 analysis showed. Investigators found two groups more ...

Disease pattern is a strong modifier of how much PCI will reduce angina and may explain prior negative trials in this space.

Doctors at Basildon Hospital have led a landmark study into a complex heart procedure for patients with chronic angina. The study, which largely took place at the Essex Cardiothoracic Centre in ...